Moroni Alice, Pedrini Elena, Tremosini Morena, Di Cecco Alessia, Cocciadiferro Dario, Novelli Antonio, Santoro Lucia, Cordiali Rosanna, Sangiorgi Luca, Gnoli Maria
Department of Rare Skeletal Disorders, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Int J Mol Sci. 2025 Apr 29;26(9):4204. doi: 10.3390/ijms26094204.
Primary osteoporosis in children and young adults often suggests a monogenic disease affecting bone microarchitecture and bone mineral density. While Osteogenesis Imperfecta (OI) is the most recognized genetic cause of recurrent fractures, many other genes involved in bone metabolism may contribute to osteoporosis. Among them, FGFR2 plays a critical role in bone growth and development by regulating osteoblast differentiation and proliferation, as well as chondrogenesis. Germline pathogenic variants are typically associated with syndromic craniosynostosis, conditions not characterized by bone fragility or osteoporosis. A report recently identified FGFR2 as a potential cause of dominant early-onset osteoporosis and bone fractures in a family. We report the case of a child affected by severe osteoporosis with multiple fractures. We performed clinical exome sequencing in trio to investigate potential genetic causes of the observed phenotype and identified a likely mosaic pathogenic variant, absent in both parental samples. Our findings provide further evidence that pathogenic variants can lead to a novel non-syndromic bone mineralization disorder, reinforcing the role of FGFR2 in the pathogenesis of early-onset osteoporosis.
儿童和年轻成人的原发性骨质疏松症通常提示一种影响骨微结构和骨密度的单基因疾病。虽然成骨不全症(OI)是复发性骨折最广为人知的遗传病因,但许多其他参与骨代谢的基因也可能导致骨质疏松症。其中,FGFR2通过调节成骨细胞的分化、增殖以及软骨形成,在骨骼生长和发育中发挥关键作用。生殖系致病性变异通常与综合征性颅缝早闭有关,这些病症并非以骨脆性或骨质疏松为特征。最近一份报告指出,FGFR2是一个家族中显性早发性骨质疏松症和骨折的潜在病因。我们报告了一名患有严重骨质疏松症并伴有多处骨折的儿童病例。我们对三联体进行了临床外显子组测序,以调查所观察到的表型的潜在遗传病因,并鉴定出一个可能的嵌合致病性变异,该变异在双亲样本中均未出现。我们的研究结果进一步证明,致病性变异可导致一种新型的非综合征性骨矿化障碍,强化了FGFR2在早发性骨质疏松症发病机制中的作用。